Santen
Showing 26 - 50 of 147
Tear, Dry Eye Syndromes Trial in Seoul (3% diquafosol eyedrops, Silicone punctal plug insertion)
Completed
- Tear
- Dry Eye Syndromes
- 3% diquafosol eyedrops
- Silicone punctal plug insertion
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University College of Medicine
Jul 7, 2022
Depressive Symptoms, Aging, Loneliness Trial (Yetitablet gaming)
Not yet recruiting
- Depressive Symptoms
- +5 more
- Yetitablet gaming
- (no location specified)
Aug 30, 2023
Non Infectious Uveitis Trial in Worldwide (DE-109 Intravitreal Injections, Sham Procedure)
Recruiting
- Non Infectious Uveitis
- DE-109 Intravitreal Injections
- Sham Procedure
-
Phoenix, Arizona
- +71 more
Nov 4, 2021
Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
- DE-126 Ophthalmic Solution 0.002% QD
- Timolol Maleate Ophthalmic Solution 0.5% BID
-
Chandler, Arizona
- +40 more
Feb 10, 2022
Normal Tension Glaucoma, Primary Open-angle Glaucoma, Glaucoma, Suspect Trial in Seongnam-si, Seoul (Eybelis ophthalmic solution
Recruiting
- Normal Tension Glaucoma
- +3 more
- Eybelis ophthalmic solution 0.002%
-
Seongnam-si, Korea, Republic of
- +7 more
Mar 6, 2022
Conjunctivitis, Vernal Trial in Paris (Cyclosporine NOVA22007 0.05%, Cyclosporine NOVA22007 0.1%, Vehicle)
Completed
- Conjunctivitis, Vernal
- Cyclosporine NOVA22007 0.05%
- +2 more
-
Paris, FranceGroupe Hospitalier Bichat-Claude Bernard
Nov 12, 2021
Diabetic Macular Edema Trial in Singapore (Aflibercept Injection [Eylea])
Unknown status
- Diabetic Macular Edema
- Aflibercept Injection [Eylea]
-
Singapore, SingaporeSingapore National Eye Centre
Apr 18, 2019
Age-Related Macular Degeneration Trial in Philippines, United States (2.0 mg DE-122 Injectable Solution + Lucentis, 4.0 mg
Completed
- Age-Related Macular Degeneration
- 2.0 mg DE-122 Injectable Solution + Lucentis
- +2 more
-
Gilbert, Arizona
- +13 more
Jun 22, 2021
Dry Eye, Meibomian Gland Dysfunction Trial in Guangzhou (Warm compresses, 3% Diquafosol Sodium Eye Drops)
Not yet recruiting
- Dry Eye
- Meibomian Gland Dysfunction
- Warm compresses
- 3% Diquafosol Sodium Eye Drops
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-Sen University
Aug 5, 2022
Students Trial in New Taipei City (Empathy experience courses and case-base clinical reasoning, case studies)
Not yet recruiting
- Students
- Empathy experience courses and case-base clinical reasoning
- case studies
-
New Taipei City, TaiwanTaipei Medical University Shuang Ho Hospital
Jul 28, 2022
Climacteric Syndrome, Menopause, Hypoestrogenism Trial in Santos (s.c 25 mg estradiol pellet)
Recruiting
- Climacteric Syndrome
- +2 more
- s.c 25 mg estradiol pellet
-
Santos, São Paulo, BrazilIrmandade Da Santa Casa De Misericórdia De Santos - Science Vall
Nov 13, 2023
Vernal Keratoconjunctivitis Trial in Worldwide (NOVA22007 ''Ciclosporin'', Placebo)
Completed
- Vernal Keratoconjunctivitis
- NOVA22007 ''Ciclosporin''
- Placebo
-
Glendale, California
- +45 more
Mar 2, 2022
Glaucoma, Primary Open Angle Trial in Tainan (Latanoprost, tafluprost)
Completed
- Glaucoma, Primary Open Angle
-
Tainan, TaiwanChi Mei Hospital Liouying Branch
Feb 3, 2021
Adaptive Expertise, Error Management Training, Learning Trial in Stanford (Error Management Training (Difficult), Error
Enrolling by invitation
- Adaptive Expertise
- +2 more
- Error Management Training (Difficult)
- +2 more
-
Stanford, CaliforniaStanford University
Jul 19, 2022
Primary Open-angle Glaucoma and Ocular Hypertension Trial in United States (DE-117 Ophthalmic Solution)
Unknown status
- Primary Open-angle Glaucoma and Ocular Hypertension
- DE-117 Ophthalmic Solution
-
Chandler, Arizona
- +30 more
Jan 7, 2020
Concordance of Molecular Classification Based on Fine Needle
Not yet recruiting
- Papillary Thyroid Cancer
-
Calgary, Alberta, CanadaFoothills Medical Centre
Nov 17, 2023
Dry Eye Trial in Shanghai (Verum Electroacupuncture, Sham Electroacupuncture)
Not yet recruiting
- Dry Eye
- Verum Electroacupuncture
- Sham Electroacupuncture
-
Shanghai, Shanghai, ChinaGuang Yang
Sep 21, 2022
Dry Eye Trial in Shenyang (Intense pulsed light, Diquafosol tetrasodium)
Not yet recruiting
- Dry Eye
- Intense pulsed light
- Diquafosol tetrasodium
-
Shenyang, Liaoning, ChinaHe Eye Hospital
Jan 19, 2023
Dry Eye, Cataract Surgery Trial in Seoul (1. Use of preservative free diquafosol ophthalmic solution after cataract surgery, 2.
Completed
- Dry Eye
- Cataract Surgery
- 1. Use of preservative free diquafosol ophthalmic solution after cataract surgery
- +2 more
-
Seoul, Korea, Republic ofDepartment of Ophthalmology, Yonsei Univeristy College of Medici
Sep 28, 2020
Dry Eye Disease With Severe Keratitis Trial in Worldwide (Open-label Ikervis, Masked Ikervis, Vehicle Comparator: Masked
Active, not recruiting
- Dry Eye Disease With Severe Keratitis
- Open-label Ikervis
- +2 more
-
Brno, Jihomoravský, Czechia
- +44 more
May 30, 2022
Open-angle Glaucoma, Ocular Hypertension Trial in Changsha, Shanghai (A preservative-free, a clear, colorless sterile aqueous
Unknown status
- Open-angle Glaucoma, Ocular Hypertension
- A preservative-free, a clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost and 5.0mg of timolol in 1mL
- A preservative-free, a clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost in 1mL
-
Changsha, China
- +1 more
Jun 16, 2020
Primary Open-angle Glaucoma and Ocular Hypertension Trial in United States (DE-117 Ophthalmic Solution QD, DE-117 Ophthalmic
Completed
- Primary Open-angle Glaucoma and Ocular Hypertension
- DE-117 Ophthalmic Solution QD
- DE-117 Ophthalmic Solution BID
-
Los Angeles, California
- +12 more
Jul 20, 2020
Myopia Trial in Singapore (DE-127 Ophthalmic Solution low dose, DE-127 Ophthalmic Solution medium dose, DE-127 Ophthalmic
Completed
- Myopia
- DE-127 Ophthalmic Solution low dose
- +3 more
-
Singapore, SingaporeSingapore National Eye Centre
Aug 25, 2020
Ocular Surface Disease in Malaysian Glaucoma Patients
Unknown status
- Primary Open-angle Glaucoma
- +4 more
- (no location specified)
Oct 25, 2020
Glaucoma and Ocular Hypertension Trial in United States (DE-117, 0.0015% tafluprost, DE-117 and 0.0015% tafluprost)
Completed
- Glaucoma and Ocular Hypertension
- DE-117
- +3 more
-
Newport Beach, California
- +9 more
Apr 16, 2018